Asarum heterotropoides extracts
showed strong antibacterial activity against selected phytopathogenic
bacteria. Bioguided isolation was conducted to obtain 11 phenanthrene
derivatives (1–11), 4 phenylpropanoids
(12–15), a flavonoid (16), and a steroid (17), including a new phenanthrene
derivative (1). In vitro bioassay results
showed that phenanthrene derivatives are the main active components
of A. heterotropoides extracts. The
new compound aristoloxazine C (1) was found to exhibit
outstanding antibacterial activity against Ralstonia
solanacearum, Xanthomonas oryzae, Erwinia carolovora, Pseudomonas syringae, and Xanthomonas
axonopodis, with MIC values of 0.05, 2.5, 2.5, 5,
and 6.25 μg/mL, respectively. These values were significantly
higher than that of the positive control, streptomycin sulfate. Aristoloxazine
C (1) also demonstrated an excellent control effect on
tobacco bacterial wilt. Physiological and biochemical experiments
combined with electron microscopy showed that the antibacterial activity
of aristoloxazine C (1) was primarily related to the
destruction of the bacterial cell wall structure. Thus, aristoloxazine
C (1) may have the potential to be used as a template
for the development of new bactericides or as a probe for the discovery
of new antimicrobial targets.